{ "items": [ "\n\n
\n \n Conference paper\n \n
\n \n\n \n \n \nLiu CL. et al, (2004), FASEB JOURNAL, 18, A654 - A654
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nDora K. et al, (2004), FASEB JOURNAL, 18, A642 - A642
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nCrane GJ. et al, (2003), J Physiol, 553, 183 - 189
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nDora KA. et al, (2003), J Vasc Res, 40, 480 - 490
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nDora KA. et al, (2003), Am J Physiol Heart Circ Physiol, 285, H119 - H126
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nCrane GJ. et al, (2003), J Vasc Res, 40, 159 - 168
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nYao X. et al, (2003), Biorheology, 40, 23 - 30
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nDora KA. et al, (2002), Am J Physiol Heart Circ Physiol, 283, H606 - H614
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nWalker SD. et al, (2002), BRITISH JOURNAL OF PHARMACOLOGY, 135
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nMcEvoy LAF. and Dora KA., (2002), BRITISH JOURNAL OF PHARMACOLOGY, 135
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nDora KA. et al, (2002), BRITISH JOURNAL OF PHARMACOLOGY, 135
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nDora KA. et al, (2002), BRITISH JOURNAL OF PHARMACOLOGY, 135
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nWalker SD. et al, (2001), Br J Pharmacol, 134, 1548 - 1554
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nDora KA. and Garland CJ., (2001), Am J Physiol Heart Circ Physiol, 280, H2424 - H2429
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nDora KA. et al, (2001), Am J Physiol Heart Circ Physiol, 280, H1272 - H1277
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nDora KA., (2001), Semin Cell Dev Biol, 12, 27 - 35
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nDora KA. et al, (2001), EDHF 2000, 118 - 125
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nDora KA., (2001), Vasc Med, 6, 43 - 50
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nDora KA. and Garland CJ., (2001), EDHF 2000, 270 - 273
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nDora KA. and Garland CJ., (2000), BRITISH JOURNAL OF PHARMACOLOGY, 131, U20 - U20
\n \n \n \n\n \n
\n \n \n